Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
MDB Capital Holdings, LLC - SIC # 6289 - SERVICES ALLIED WITH THE EXCHANGE OF SECURITIES OR COMMODITIES, N
Ticker
Exchange
SIC #
Website
Latest Ticker
MDBH
Nasdaq
6289
www.mdb.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for MDB Capital Holdings, LLC
MDB Capital Holdings Announces Transitions In Its Board of Directors
- Jun 2nd, 2025 3:20 pm
ClearSign Technologies Corporation Announces Changes to Board of Directors
- May 27th, 2025 2:05 pm
MDB Capital Holdings Provides First Quarter 2025 Update
- May 21st, 2025 7:00 am
New PatentVest Pulse Report Reveals IP Gaps in Billion-Dollar Humanoid Robotics Startups
- May 14th, 2025 10:00 am
MDB Capital Holdings to Host First Quarter 2025 Results Conference Call on Wednesday May 21, 2025, at 4:30 p.m. Eastern Time
- May 14th, 2025 6:55 am
New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $400B Brain-Computer Interface (BCI) Market
- Apr 1st, 2025 8:00 am
MDB Capital Holdings Provides Fourth Quarter and Full Year 2024 Update
- Mar 31st, 2025 2:05 pm
MDB Capital Holdings to Host Fourth Quarter and Full Year 2024 Results Conference Call on Monday March 31, 2025, at 4:30 p.m. Eastern Time
- Mar 24th, 2025 6:50 am
New PatentVest Pulse Report Reveals Transformative Trends in the AI Data Center Patent Race
- Mar 5th, 2025 8:00 am
eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering
- Feb 19th, 2025 6:25 am
Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes
- Feb 12th, 2025 6:50 am
Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol
- Feb 10th, 2025 9:00 am
Rethinking Diabetes Care: PatentVest Pulse Unveils Key Insights on the Expanding CGM Market and the Innovations Driving Change
- Jan 7th, 2025 8:00 am
MDB Capital Holdings Provides Third Quarter 2024 Update
- Nov 21st, 2024 2:05 pm
Invizyne Technologies Selected for $2 Million Project to Advance Sustainable Aviation Fuel Capabilities
- Nov 19th, 2024 7:05 am
MDB Capital Holdings to Host Third Quarter 2024 Results Conference Call on Thursday November 21, 2024, at 4:30 p.m. Eastern Time
- Nov 15th, 2024 7:05 am
Invizyne Technologies Announces Closing of Initial Public Offering
- Nov 14th, 2024 2:05 pm
Invizyne’s Nasdaq IPO Marks New Era of Biomanufacturing
- Nov 13th, 2024 2:05 pm
Invizyne Technologies Begins Trading on NASDAQ
- Nov 13th, 2024 7:05 am
Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024
- Nov 12th, 2024 8:52 am
Scroll